<DOC>
	<DOCNO>NCT01295450</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tolerability Apevinat BC compare vitamin complex , treatment lack appetite prevention deficiency B C vitamin .</brief_summary>
	<brief_title>Study Evaluate Efficacy Tolerability Apevinat BC Compared Vitamin Complex</brief_title>
	<detailed_description>Apevinat BC present formula cyproheptadine hydrochloride , antihistamine anti-serotonin stimulant appetite property associate vitamin B complex C , balance amount . This combination specially formulate adequately serve patient anorexia represent lack appetite appetite divert diet without necessary vitamin . For anorexic patient common B C hypovitaminosis , use Apevinat BC synergistic joint action increase appetite facilitate correction diet also supplement B C vitamin , association decrease tolerability safety hit adequately purpose therapeutic orexigenic . The current study compare efficacy tolerability Apevinat BC vitamin complex administer three time day , prevention treatment lack appetite B C hypovitaminosis .</detailed_description>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Flavin Mononucleotide</mesh_term>
	<mesh_term>Cyproheptadine</mesh_term>
	<criteria>Patients present lack appetite ; Wash 20 day ingestion similar drug ; Responsible least able understand maintain adherence protocol ; Patients ethnic group sex , age 714 year ; Responsible minor must consent participate study , sign consentiment term ; Responsible minor able understand proper use medication ; Patients parasitic infection ; Patients angle closure glaucoma open ; Patients predisposition urinary retention ; Patients peptic ulcer stenotic pylorusduodenal obstruction ; debilitate patient acute asthma attack ; Patients poor appetite cause serious illness ; Patients take medication depress central nervous system ; Patients take medication monoamine oxidase inhibitor , tricyclic antidepressant , phenothiazine , probenecid , levodopa , phenytoin , phenobarbital , chloramphenicol , cyclophosphamide , cyclosporine , chlorambucil , corticotrophin , mercaptopurine , isoniazid , penicillin , estrogens , contraceptive , haloperidol , ipatr√≥pico , barbiturate , Primidone , salicylates ; Patients know hypersensitivity component formula ; Patients participate another clinical trial ; Inability compliance protocol ; Any condition opinion investigator would prohibit inclusion patient compliance protocol .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Phase III</keyword>
	<keyword>Apevinat BC</keyword>
	<keyword>Lack appetite</keyword>
</DOC>